Gray E, Padilla A, Barrowcliffe T W
National Institute for Biological Standards and Control, Potters Bar, Herts, UK.
Haemostasis. 1993 Mar;23 Suppl 1:99-102. doi: 10.1159/000216916.
Antithrombotic activities of low molecular weight heparins (LMWHs) in a venous stasis thrombosis model, when compared to unfractionated heparin (UFH), correlated better with anti-IIa activities and inhibition of thrombin generation than with anti-Xa activities. The relative antithrombotic potencies of LMWHs were closer to inhibitory activity in thrombin generation with platelet-poor plasma than platelet-rich plasma. Comparing activities in intrinsic and extrinsic systems, higher concentrations of heparins were required in vitro to inhibit intrinsic thrombin generation than extrinsic thrombin production; however, higher doses were required to prevent in vivo thrombotic events initiated via the extrinsic pathway.
与普通肝素(UFH)相比,低分子量肝素(LMWHs)在静脉淤滞性血栓形成模型中的抗血栓活性与抗IIa活性及凝血酶生成抑制的相关性,优于与抗Xa活性的相关性。LMWHs的相对抗血栓效力在乏血小板血浆中比富血小板血浆中更接近凝血酶生成抑制活性。比较内源性和外源性系统中的活性,体外抑制内源性凝血酶生成所需的肝素浓度高于外源性凝血酶生成;然而,预防通过外源性途径引发的体内血栓形成事件则需要更高剂量。